Dendritic cells resurrect antigens from dead cells

Trends in Immunology

Volumn 22, Issue 3, 2001, Pages 141-148

  Larsson, Marie ^a   Fonteneau, Jean Francois ^a   Bhardwaj, Nina ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; BIOLOGICAL MODEL; CELL DEATH; CELL FUNCTION; CELLULAR IMMUNITY; DENDRITIC CELL; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; MACROPHAGE; NONHUMAN; REVIEW; T LYMPHOCYTE; TUMOR IMMUNITY; VIRUS INFECTION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; AUTOIMMUNITY; CELL DEATH; CROSS REACTIONS; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNE TOLERANCE; MODELS, IMMUNOLOGICAL; NEOPLASMS; T-LYMPHOCYTES; VIRUSES;

EID: 0034920535     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(01)01860-9     Document Type: Review

References (66)

1. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay
2. In vitro cell-mediated immune responses to the male specific (H-Y) antigen in mice
3. H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes
4. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens
5. Constitutive class I-restricted exogenous presentation of self antigens in vivo
6. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens
7. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
8. Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation
9. + T cells
10. + T-cell responses to infectious agents, tumors, transplants, and vaccines
11. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter
12. + T cell help
13. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
14. +) T cells
15. +) cytotoxic T lymphocytes
16. + T cells
17. Dendritic cells and the control of immunity
18. Dendritic cells
19. Active immunization of humans with dendritic cells
20. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
21. Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells
22. Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells
23. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells
24. Immunogenicity of apoptotic cells in vivo: Role of antigen load, antigen-presenting cells, and cytokines
25. Efficient presentation of phagocytosed cellular fragments on the MHC class II products of dendritic cells
26. - dendritic cells cross-prime cytotoxic T cells in vivo
27. Processing of engulfed apoptotic bodies yields T cell epitopes
28. Exogenous antigens gain access to the major histocompatibility complex class I processing pathway in B cells by receptor-mediator uptake
29. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages
30. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages
31. A mechanism for the specific immunogenicity of heat shock-chaperoned peptides
32. Macrophages that have ingested apoptosis cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2 and PAF
33. The macrophage haunted by cell ghosts: A pathogen grows
34. +) T lymphocyte responses
35. Heat shock proteins come of age: Primitive functions acquire new roles in an adaptive world
36. Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes
37. Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization
38. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes
39. + T cells for efficient tumor cell lysis
40. Cross-presentation of tumor antigens to effector T cells is sufficient to mediate effective immunotherapy of established intracranial tumors
41. Consequences of cell death. Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
42. Natural adjuvants: Endogenous activators of dendritic cells
43. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function
44. Canarypox-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis factor-α secretion
45. Inhibition of dendritic cell maturation by herpes simplex virus
46. CD91: A receptor got heat shock protein gp96
47. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake
48. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappaB pathway
49. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
50. 5 integrin recruits the CrkII-Dock180-Rac1 complex for phagocytosis of apoptotic cells
51. Thymocytes appear to ignore class I major histocompatibility complex antigens expressed on the thymus epithelial cells
52. + T-cell tolerance to peripherally expressed antigens
53. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction
54. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo
55. +) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1
56. Tumor-specific and anti-neuronal killer cells in paraneoplastic cerebellar degeneration
57. Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells
58. Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T-cell response
59. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production
60. + T cells with regulatory properties by repetitive stimulation with allogeneic immature dendritic cells
61. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
62. Building better vaccines: How apoptotic cell death can induce inflammation and activate innate and adaptive immunity
63. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
64. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
65. Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
66. Treatment of solid tumours in children with tumour-lysate-pulsed dendritic cells